Tumor-infiltrating CD8+ T cells are associated with disease progression in cancers, and cytotoxicity of CD8+ T cells has spurred great interest in cancer immunotherapy (Fu et al., 2007; Yang et al., 2016). This evidence concerns the gene CD8A and cancer.